INTERNATIONAL PATENT: DR. FALK PHARMA GMBH FILES APPLICATION FOR "BENZISOXAZOLE COMPOUND FOR TREATMENT OF KMO MEDIATED DISORDERS"

GENEVA, March 23 -- DR. FALK PHARMA GMBH (Leinenweberstr. 579108 Freiburg) filed a patent application (PCT/EP2025/075751) for "BENZISOXAZOLE COMPOUND FOR TREATMENT OF KMO MEDIATED DISORDERS" on Sep 10, 2025. With publication no. WO/2026/057633, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAVIDGE, Jonathan (c/o Dr. Falk Pharma GmbHLeinenweberstr. 579108 Freiburg), WEBSTER, Scott (c/o Dr. Falk Pharma GmbHLeinenweberstr. 579108 Freiburg), MOLE, Damian (c/o Dr. Falk Pharma GmbHLeinenweberstr. 579108 Freiburg)

Abstract: T...